InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the full record of transactions filed by LOUMEAU ERIC J, Chief Executive Officer. Officer active across 1 company, notably Anaptysbio, INC. Cumulatively, 6 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €22k. History available since 4 November 2021. The latest transaction was disclosed on 8 June 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
2,500 shares@ US$14.020.0018% mcap24.1% of flowCommon StockSEC:0001209191-22-036020:0
1,146 shares@ US$20.500.0012% mcap16.5% of flowCommon StockSEC:0001209191-22-031028:0
523 shares@ US$22.030.0005% mcap7.4% of flowCommon StockSEC:0001209191-21-065168:0
523 shares@ US$22.030.0005% mcap25.0% of flowCommon StockSEC:0001209191-21-065168
2,500 shares@ US$14.020.0016% mcap22.2% of flowCommon StockSEC:0001209191-21-063260:0
2,500 shares@ US$14.020.0016% mcap75.0% of flowCommon StockSEC:0001209191-21-063260
6 of 6 declarations
About LOUMEAU ERIC J
Eric J. Loumeau is the Chief Operating Officer and General Counsel at AnaptysBio, Inc. He oversees the company's operations while ensuring legal compliance. AnaptysBio is a biopharmaceutical company focused on developing immunological treatments.
